OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 associated mucormycosis: evolving technologies for early and rapid diagnosis
Rachel Samson, Mahesh Dharne
3 Biotech (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach
Asim Azhar, Wajihul Hasan Khan, Parvez Anwar Khan, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 4, pp. 466-479
Open Access | Times Cited: 40

Management of Invasive Infections in Diabetes Mellitus: A Comprehensive Review
Anjum Khanam, Gavirangappa Hithamani, Naveen Jayapala, et al.
Biologics (2023) Vol. 3, Iss. 1, pp. 40-71
Open Access | Times Cited: 17

Mucormycosis, Past and Present: A Comprehensive Review
Ishita Gupta, Pritika Baranwal, Gagandeep Singh, et al.
Future Microbiology (2023) Vol. 18, Iss. 3, pp. 217-234
Closed Access | Times Cited: 15

COVID-19-Associated Pulmonary Mucormycosis
Vidya Krishna, N.K. Bansal, Jaymin B. Morjaria, et al.
Journal of Fungi (2022) Vol. 8, Iss. 7, pp. 711-711
Open Access | Times Cited: 20

Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis
Laura C. García-Carnero, Héctor M. Mora‐Montes
Journal of Fungi (2022) Vol. 8, Iss. 5, pp. 445-445
Open Access | Times Cited: 19

Mucormycosis diagnosis revisited: Current and emerging diagnostic methodologies for the invasive fungal infection (Review)
Deepa Ponnaiyan, C.m. Anitha, P. S. G. Prakash, et al.
Experimental and Therapeutic Medicine (2022) Vol. 25, Iss. 1
Open Access | Times Cited: 16

Nanotechnology-based fungal detection and treatment: current status and future perspective
Vinay Chaudhari, Vaishnavi Vairagade, Ami Thakkar, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 1, pp. 77-97
Closed Access | Times Cited: 7

A case control investigation of COVID-19 associated mucormycosis in India
Tanu Anand, Aparna Mukherjee, Aanchal Satija, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 10

Satellite Epidemic of Covid-19 Associated Mucormycosis in India: A Multi-Site Observational Study
Aanchal Satija, Tanu Anand, Aparna Mukherjee, et al.
Mycopathologia (2023) Vol. 188, Iss. 5, pp. 745-753
Closed Access | Times Cited: 5

Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review
Maria Panagiota Almyroudi, Karolina Akinosoglou, Jordi Rello, et al.
Diagnostics (2022) Vol. 12, Iss. 12, pp. 3092-3092
Open Access | Times Cited: 9

A Comprehensive Review on the Management of COVID-19-Associated Mucormycosis (CAM): The New Basics
Divyam Girdhar, Ekta Manocha
BioMed (2022) Vol. 2, Iss. 2, pp. 181-198
Open Access | Times Cited: 8

Epidemiology, Risk Factors, Diagnosis and Treatment of Mucormycosis (Black Fungus): A Review
Pragati Upadhayay, Keshav Bansal, Ahsas Goyal
Current Pharmaceutical Biotechnology (2023) Vol. 24, Iss. 13, pp. 1645-1656
Closed Access | Times Cited: 3

Antimycotic effect of 3-phenyllactic acid produced by probiotic bacterial isolates against Covid-19 associated mucormycosis causing fungi
Ravikumar Lunavath, Saddam Hussain Mohammad, Kiran Kumar Bhukya, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0279118-e0279118
Open Access | Times Cited: 2

COVID-19-associated disseminated mucormycosis: An autopsy case report
Daisuke Kyuno, Terufumi Kubo, Mitsuhiro Tsujiwaki, et al.
World Journal of Clinical Cases (2022) Vol. 10, Iss. 28, pp. 10358-10365
Open Access | Times Cited: 2

COVID-19 associated invasive mycoses
O. Kutsevalova, A. Antonets, V. Krylov, et al.
Immunopathology Allergology Infectology (2021) Vol. 2021, Iss. 4, pp. 49-53
Open Access | Times Cited: 2

A case control investigation of COVID-19 associated Mucormycosis in India
Tanu Anand, Aparna Mukherjee, Aanchal Satija, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1

Emerging Mucormycosis: Problems and Treatments
A Varaiya, A. Sundaresan
(2023), pp. 97-125
Closed Access

Prevention and Treatment of COVID-19-Associated Mucormycosis
Kevin Grafmiller, Jivianne T. Lee
Current Treatment Options in Allergy (2023) Vol. 10, Iss. 2, pp. 83-92
Open Access

Page 1

Scroll to top